GEIST:UPC Searchengine

ORD_44709/2024

Amgen AB, Amgen s.r.l., Amgen GmbH, Amgen Technology (Ireland) Unlimited Company, Amgen Biofarmacêutica Lda., Amgen S.A.S., Amgen Zdravila D.O.O., Amgen N.V.

Datum
2024-08-08
Kammer
Luxembourg (LU)
Verfahrensart
Generic application
Sprache
EN

Metadaten

Fall-IDORD_44709-2024-289ee0991426
Aktenzeichen
RegisterzeichenORD_44709/2024
EntscheidungsreferenzORD_44709/2024
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 3

1 ORDER of the Court of Appeal of the Unified Patent Court issued on 8 August 2024 HEADNOTES - It follows from Rule 278.1 and 2 RoP that written pleadings, like the Statement of grounds of appeal in the case-at-hand, are served by the Registry in the electronic CMS of the Court unless service cannot be effected by means of electronic communication. - Prior communication between the parties themselves of the written pleading via another electronic system like the German special electronic lawyer’s mailbox (besonderes elektronisches Anwaltspostfach, (beA)) cannot be considered as effective service under Rule 278.1 RoP. KEYWORD - Service APPELLANT (APPLICANT IN THE PROCEEDINGS BEFORE THE COURT OF FIRST INSTANCE) Alexion Pharmaceuticals, Inc. 121 Seaport Blvd, 02210 Boston (MA), United States  ...